(Q40527104)

21 September 2017

title

HLA-DR signaling inhibits Fas-mediated apoptosis in A375 melanoma cells (English)

1 reference

Catherine Alcaide-Loridan

21 September 2017

author

5

object named as

Catherine Alcaide-Loridan

0 references

author name string

Fawzi Aoudjit

1

1 reference

21 September 2017

Wenyan Guo

2

1 reference

21 September 2017

Jean-Vincent Gagnon-Houde

3

1 reference

21 September 2017

Jean-Gabriel Castaigne

4

1 reference

21 September 2017

Dominique Charron

6

1 reference

21 September 2017

Reem Al-Daccak

7

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

Experimental Cell Research

21 September 2017

published in

1 reference

21 September 2017

volume

299

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

79-90

1 reference

Progress in human tumour immunology and immunotherapy

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

T cell-mediated immune responses in melanoma: implications for immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

T-cell responses of vaccinated cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Death and anti-death: tumour resistance to apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

The CD95(APO-1/Fas) DISC and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

The biological role of the Fas/FasL system during tumor formation and progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Apoptosis and melanoma: molecular mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Capture and processing of exogenous antigens for presentation on MHC molecules.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Ligation of HLA-DR molecules on B cells induces enhanced expression of IgM heavy chain genes in association with Syk activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Monocytes are differentially activated through HLA-DR, -DQ, and -DP molecules via mitogen-activated protein kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

MHC class II signaling in antigen-presenting cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Constitutive expression of MHC class II genes in melanoma cell lines results from the transcription of class II transactivator abnormally initiated from its B cell-specific promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: association with NY-ESO-1 antibody production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

DNA content and MHC class II antigen expression in malignant melanoma: clinical course

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Prognostic immunohistochemical markers of primary human melanomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

SHIP recruitment attenuates Fc gamma RIIB-induced B cell apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Combined action of ERK and NF kappa B mediates the protective effect of phorbol ester on Fas-induced apoptosis in Jurkat cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Ligation of major histocompatibility complex class II molecules mediates apoptotic cell death in resting B lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

A CD18-dependent protein kinase C beta-mediated alternative cell death pathway of activated monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Matrix attachment regulates Fas-induced apoptosis in endothelial cells: a role for c-flip and implications for anoikis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Fas-induced apoptosis in human malignant melanoma cell lines is associated with the activation of the p34(cdc2)-related PITSLRE protein kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Intracellular Phosphotyrosine Induction by Major Histocompatibility Complex Class II Requires Co-aggregation with Membrane Rafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Induction of apoptosis by cancer chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Get a ligand, get a life: integrins, signaling and cell survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

The phosphoinositide 3-kinase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

In vivo cooperation between Bcl-xL and the phosphoinositide 3-kinase-Akt signaling pathway for the protection of epidermal keratinocytes from apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Mitogen-activated protein kinases control p27/Kip1 expression and growth of human melanoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Programmed cell death and the caspases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Resistance to CD95/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Two CD95 (APO-1/Fas) signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Bcl-2 and bcl-xL antisense oligonucleotides induce apoptosis in melanoma cells of different clinical stages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Signaling through MHC class II molecules blocks CD95-induced apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Integrin alpha2beta1 inhibits Fas-mediated apoptosis in T lymphocytes by protein phosphatase 2A-dependent activation of the MAPK/ERK pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

cFLIP-L inhibits p38 MAPK activation: an additional anti-apoptotic mechanism in bile acid-mediated apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Resistance of short term activated T cells to CD95-mediated apoptosis correlates with de novo protein synthesis of c-FLIPshort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Oncogenic K-Ras and basic fibroblast growth factor prevent Fas-mediated apoptosis in fibroblasts through activation of mitogen-activated protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Regulation of Fas-mediated apoptosis by N-ras in melanoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Signaling through HLA-DR induces PKC beta-dependent B cell death outside rafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Differential susceptibility to CD95 (Apo-1/Fas) and MHC class II-induced apoptosis during murine dendritic cell development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

HLA-DR-mediated apoptosis susceptibility discriminates differentiation stages of dendritic/monocytic APC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

High levels of Fas ligand and MHC class II in the absence of CD80 or CD86 expression and a decreased CD4+ T cell Infiltration, enables murine skin tumours to progress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

Characterization of the major histocompatibility complex class II binding site on LAG-3 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.011

10.1016/J.YEXCR.2004.05.011

7 January 2021

Identifiers

DOI

1 reference

21 September 2017

1 reference